{"entity":{"edinet_code":"E01001","sec_code":"4992","name_ja":"北興化学工業株式会社","name_en":"HOKKO CHEMICAL INDUSTRY CO.,LTD.","industry":"化学","industry_en":"Chemicals"},"names_note":"English company names are as filed: each company's own annual report states its English name on the cover page. For a company that files no annual report, EDINET's filer registry is used instead. The as-filed Japanese name is always returned alongside.","filing":{"doc_id":"S100XVAV","filer_name":"北興化学工業株式会社","filer_name_en":"HOKKO CHEMICAL INDUSTRY CO.,LTD.","period_end":"2025-11-30","filed_date":"2026-03-30","sha256":"7b825eef5fac44204666b0460082254e37747ae99c59fe6105af5a2dd1b48db1","status":"clean"},"basis":{"measurement":"carrying_amount","entity_scope":"parent_only","share_scope":"both","trust_included":"unknown","as_of":"2025-11-30","period_type":"annual","labels":{"measurement":"Balance-sheet carrying amount. Under Japanese GAAP listed equities are carried at market with the valuation difference in other comprehensive income, so carrying amount and acquisition cost diverge enormously on positions bought decades ago.","entity_scope":"The reporting company itself (提出会社) — the holding company, excluding the group holders it names separately.","share_scope":"Listed and unlisted shares together.","trust_included":"The filing does not state whether retirement-benefit-trust shares are included. Never guessed — shares contributed to such a trust leave the holder's balance sheet while the settlor normally keeps the right to instruct the vote.","period_type":"From an annual securities report (有価証券報告書). The policy shareholding table appears only in the annual report."},"not_comparable":"Figures are balance-sheet CARRYING AMOUNT at fiscal year end, from the annual securities report. They are NOT comparable with the acquisition-cost or book-value-reduction figures quoted in press coverage and IR presentations, and NOT comparable with interim (half-year) figures, which this product does not hold. Always state the basis with the number, and use check_claim before setting one of our figures against a published one."},"basis_note":"The basis every yen figure on this response is on. entity_scope is read from the filing's own disclosing entities, not assumed: scale_entities and flows each carry their own entity_scope and share_scope, and a figure quoted for one entity is not the group figure.","holdings":[{"holder_table":"reporting","held_name_raw":"野村マイクロ・サイエンス㈱","held_name_en":"Nomura Micro Science Co.,Ltd.","held_sec_code":"6254","match_status":"matched","shares":4200000,"book_value_yen":13104000000,"prior_shares":4350000,"prior_book_value_yen":7682000000,"purpose_ja":"環境規制に関する情報収集や環境対策技術等の支援などの面での協力関係を維持するため。","reciprocal":"有","pct_outstanding":10.969265163703223,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":24.77126654064272,"pct_of_holder_assets":16.88659793814433,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52900000000,"holder_total_assets_yen":77600000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"日産化学㈱","held_name_en":"Nissan Chemical Corporation","held_sec_code":"4021","match_status":"matched","shares":192000,"book_value_yen":1014000000,"prior_shares":192000,"prior_book_value_yen":1001000000,"purpose_ja":"農薬事業における業務（購買や販売）面での協力関係を維持するため。","reciprocal":"有","pct_outstanding":0.14302656122430737,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":1.9168241965973536,"pct_of_holder_assets":1.306701030927835,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52900000000,"holder_total_assets_yen":77600000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"野村ホールディングス㈱","held_name_en":"Nomura Holdings, Inc.","held_sec_code":"8604","match_status":"matched","shares":457171,"book_value_yen":538000000,"prior_shares":457171,"prior_book_value_yen":412000000,"purpose_ja":"資本政策や株主政策、コーポレートガバナンス情報の収集、ビジネス機会創出など財務・経営戦略面での協力関係を維持するため。","reciprocal":"有","pct_outstanding":0.015755192335214017,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":1.0170132325141776,"pct_of_holder_assets":0.6932989690721649,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52900000000,"holder_total_assets_yen":77600000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"ＯＡＴアグリオ㈱","held_name_en":"OAT Agrio Co., Ltd.","held_sec_code":"4979","match_status":"matched","shares":226400,"book_value_yen":510000000,"prior_shares":201200,"prior_book_value_yen":406000000,"purpose_ja":"農薬事業における業務（販売や生産）面や研究開発面での協力関係を維持するため。なお、業務面おける協力体制を維持するため、同社株式を追加取得しました。","reciprocal":"有","pct_outstanding":2.2444953355342077,"pct_unavailable":null,"pct_basis_period_end":"2025-12-31","pct_share_classes":1,"pct_of_holder_equity":0.9640831758034026,"pct_of_holder_assets":0.6572164948453608,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52900000000,"holder_total_assets_yen":77600000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"日本曹達㈱","held_name_en":"Nippon Soda Co., Ltd.","held_sec_code":"4041","match_status":"matched","shares":131840,"book_value_yen":469000000,"prior_shares":131840,"prior_book_value_yen":357000000,"purpose_ja":"農薬事業とファインケミカル事業における業務（購買や販売）面や研究開発面での協力関係を維持するため。","reciprocal":"有","pct_outstanding":0.24558512126715365,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.8865784499054821,"pct_of_holder_assets":0.604381443298969,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52900000000,"holder_total_assets_yen":77600000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"㈱東邦アグロ","held_name_en":null,"held_sec_code":null,"match_status":"unmatched","shares":592391,"book_value_yen":387000000,"prior_shares":592391,"prior_book_value_yen":400000000,"purpose_ja":"韓国における唯一の代理店として継続的・安定的な関係を維持するため。","reciprocal":"無","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":null,"pct_share_classes":null,"pct_of_holder_equity":0.7315689981096408,"pct_of_holder_assets":0.49871134020618557,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52900000000,"holder_total_assets_yen":77600000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"小野薬品工業㈱","held_name_en":"ONO　PHARMACEUTICAL　CO.,　LTD.","held_sec_code":"4528","match_status":"matched","shares":150000,"book_value_yen":330000000,"prior_shares":150000,"prior_book_value_yen":260000000,"purpose_ja":"ファインケミカル事業の強化分野における情報交換等協力関係を維持し、企業基盤の安定化を図るため。","reciprocal":"有","pct_outstanding":0.03136069672596417,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.6238185255198487,"pct_of_holder_assets":0.4252577319587629,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52900000000,"holder_total_assets_yen":77600000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"㈱りそなホールディングス","held_name_en":"Resona Holdings, Inc.","held_sec_code":"8308","match_status":"matched","shares":180000,"book_value_yen":286000000,"prior_shares":180000,"prior_book_value_yen":225000000,"purpose_ja":"傘下金融機関との資金取引、傘下関連企業との各種取引、事業推進に資する情報の収集など財務・経営戦略面での協力関係を維持するため。","reciprocal":"無","pct_outstanding":0.007957415920530942,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.5406427221172023,"pct_of_holder_assets":0.36855670103092786,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52900000000,"holder_total_assets_yen":77600000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"㈱ひろぎんホールディングス","held_name_en":"Hirogin Holdings, Inc.","held_sec_code":"7337","match_status":"matched","shares":181195,"book_value_yen":281000000,"prior_shares":181195,"prior_book_value_yen":204000000,"purpose_ja":"傘下金融機関との安定的な資金取引のほか、地域経済情報の収集など財務・経営戦略面での協力関係を維持するため。","reciprocal":"無","pct_outstanding":0.06075940195284698,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.5311909262759924,"pct_of_holder_assets":0.36211340206185566,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52900000000,"holder_total_assets_yen":77600000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"信越化学工業㈱","held_name_en":"Shin-Etsu Chemical Co., Ltd.","held_sec_code":"4063","match_status":"matched","shares":57500,"book_value_yen":270000000,"prior_shares":57500,"prior_book_value_yen":319000000,"purpose_ja":"ファインケミカル事業における業務（生産や販売）面や研究開発面での協力・協業関係を維持するため。","reciprocal":"無","pct_outstanding":0.0030969405988992456,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.5103969754253308,"pct_of_holder_assets":0.3479381443298969,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52900000000,"holder_total_assets_yen":77600000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"住友化学㈱","held_name_en":"SUMITOMO CHEMICAL COMPANY, LIMITED","held_sec_code":"4005","match_status":"matched","shares":426124,"book_value_yen":203000000,"prior_shares":426124,"prior_book_value_yen":154000000,"purpose_ja":"農薬事業とファインケミカル事業における業務（購買や販売）面や研究開発面での協力関係を維持するため。","reciprocal":"有","pct_outstanding":0.025819794423856433,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.3837429111531191,"pct_of_holder_assets":0.2615979381443299,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52900000000,"holder_total_assets_yen":77600000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"日本新薬㈱","held_name_en":"Nippon Shinyaku Co., Ltd.","held_sec_code":"4516","match_status":"matched","shares":36000,"book_value_yen":131000000,"prior_shares":36000,"prior_book_value_yen":157000000,"purpose_ja":"ファインケミカル事業における業務（販売）面や強化分野における協力関係を維持するため。","reciprocal":"有","pct_outstanding":0.053411683129136515,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.24763705103969755,"pct_of_holder_assets":0.16881443298969073,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52900000000,"holder_total_assets_yen":77600000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"㈱三井住友フィナンシャルグループ","held_name_en":"Sumitomo Mitsui Financial Group, Inc.","held_sec_code":"8316","match_status":"matched","shares":25560,"book_value_yen":120000000,"prior_shares":25560,"prior_book_value_yen":94000000,"purpose_ja":"傘下金融機関との資金取引のほか、中国をはじめとした海外の政治経済情報の収集など財務・経営戦略面での協力関係を維持するため。","reciprocal":"無","pct_outstanding":0.0006695586851736739,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.22684310018903592,"pct_of_holder_assets":0.15463917525773196,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52900000000,"holder_total_assets_yen":77600000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"日本化薬㈱","held_name_en":"NIPPON KAYAKU CO.,LTD.","held_sec_code":"4272","match_status":"matched","shares":69877,"book_value_yen":114000000,"prior_shares":69877,"prior_book_value_yen":88000000,"purpose_ja":"農薬事業とファインケミカル事業における業務（購買や販売）面での協力関係を維持するため。","reciprocal":"有","pct_outstanding":0.0470631736407972,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.21550094517958412,"pct_of_holder_assets":0.14690721649484537,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52900000000,"holder_total_assets_yen":77600000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"長瀬産業㈱","held_name_en":"NAGASE & CO., LTD.","held_sec_code":"8012","match_status":"matched","shares":30385,"book_value_yen":112000000,"prior_shares":30385,"prior_book_value_yen":93000000,"purpose_ja":"ファインケミカル事業における業務（販売）面での協力関係を維持するため。","reciprocal":"有","pct_outstanding":0.029589577418278452,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.21172022684310018,"pct_of_holder_assets":0.14432989690721648,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52900000000,"holder_total_assets_yen":77600000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"三井化学㈱","held_name_en":"Mitsui Chemicals, Inc.","held_sec_code":"4183","match_status":"matched","shares":20000,"book_value_yen":79000000,"prior_shares":20000,"prior_book_value_yen":69000000,"purpose_ja":"農薬事業における業務（購買や販売）面や研究開発面での協力関係を維持するため。","reciprocal":"無","pct_outstanding":null,"pct_unavailable":"issuer share count changed over this window","pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.14933837429111532,"pct_of_holder_assets":0.1018041237113402,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52900000000,"holder_total_assets_yen":77600000000,"implausible":false,"reciprocal_held_both_ways":false,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"㈱クレハ","held_name_en":"KUREHA CORPORATION","held_sec_code":"4023","match_status":"matched","shares":10800,"book_value_yen":43000000,"prior_shares":10800,"prior_book_value_yen":30000000,"purpose_ja":"主に農薬事業における業務（購買）面や研究開発面での協力関係を維持するため。","reciprocal":"有","pct_outstanding":0.028258254595936918,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.08128544423440454,"pct_of_holder_assets":0.055412371134020616,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52900000000,"holder_total_assets_yen":77600000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false}],"holders":[{"holder_name":"住友化学株式会社","holder_name_en":"SUMITOMO CHEMICAL COMPANY, LIMITED","holder_sec_code":"4005","doc_id":"S100YAUO","period_end":"2026-03-31","holder_table":"reporting","shares":1968000,"book_value_yen":3359000000,"prior_shares":1968000,"prior_book_value_yen":2529000000,"purpose_ja":"アグロ＆ライフソリューション部門の顧客として良好な関係を維持・強化していくことの重要性等に加え、資本コストを勘案した配当・取引額等の定量的な評価の実施を通じて、総合的に判断し保有しております。","reciprocal":"有","pct_outstanding":7.633726657737637,"pct_unavailable":null,"pct_basis_period_end":"2025-11-30","pct_share_classes":1,"pct_of_holder_equity":0.3330213633353294,"pct_of_holder_assets":0.09864785769099403,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":1008644000000,"holder_total_assets_yen":3405041000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社　りそなホールディングス","holder_name_en":"Resona Holdings, Inc.","holder_sec_code":"8308","doc_id":"S100YDP3","period_end":"2026-03-31","holder_table":"largest","shares":1287200,"book_value_yen":2197000000,"prior_shares":1314100,"prior_book_value_yen":1688000000,"purpose_ja":"事業上の関係を総合的に勘案し、中長期的かつ安定的な取引関係の構築を図るため。","reciprocal":"有","pct_outstanding":4.99295373670726,"pct_unavailable":null,"pct_basis_period_end":"2025-11-30","pct_share_classes":1,"pct_of_holder_equity":0.07502485176871856,"pct_of_holder_assets":0.0028795028832513487,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":2928363000000,"holder_total_assets_yen":76297892000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"野村ホールディングス株式会社","holder_name_en":"Nomura Holdings, Inc.","holder_sec_code":"8604","doc_id":"S100YC5C","period_end":"2026-03-31","holder_table":"reporting","shares":836000,"book_value_yen":1427000000,"prior_shares":836000,"prior_book_value_yen":1074000000,"purpose_ja":"コーポレート部門を中心とした、ビジネス機会創出、取引関係・地域経済との関係性の維持・強化・拡大のため","reciprocal":"有","pct_outstanding":3.2427822590796063,"pct_unavailable":null,"pct_basis_period_end":"2025-11-30","pct_share_classes":1,"pct_of_holder_equity":0.037017677432576335,"pct_of_holder_assets":0.0022778816020355675,"holder_equity_basis":"usgaap_consolidated","holder_equity_yen":3854915000000,"holder_total_assets_yen":62645925000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社ひろぎんホールディングス","holder_name_en":"Hirogin Holdings, Inc.","holder_sec_code":"7337","doc_id":"S100YCZN","period_end":"2026-03-31","holder_table":"largest","shares":360000,"book_value_yen":615000000,"prior_shares":360000,"prior_book_value_yen":463000000,"purpose_ja":"同社は、当社グループの主要営業地域に主要な製造拠点を有する農薬・ファインケミカル製品の製造・販売事業者であり、地域経済における産業・雇用創出に貢献していると認識しております。同社との各種取引（役職員との取引含む）における収益等及び当該株式の配当金額の合計と、株式保有に係る資本コストとの比較分析及び当該株式の配当金RORAと、保有する上場政策保有株式全体の配当金RORA（加重平均）との比較分析により、定量的な保有効果等を含め保有意義を確認しております。当社の主要営業地域の中核企業として認識しており、上記保有目的の通り、当社の企業価値向上に資するものとして保有しております。","reciprocal":"有","pct_outstanding":1.3964134130007873,"pct_unavailable":null,"pct_basis_period_end":"2025-11-30","pct_share_classes":1,"pct_of_holder_equity":0.10811780093666934,"pct_of_holder_assets":0.005036612074978529,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":568824000000,"holder_total_assets_yen":12210589000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"小野薬品工業株式会社","holder_name_en":"ONO　PHARMACEUTICAL　CO.,　LTD.","holder_sec_code":"4528","doc_id":"S100YOIE","period_end":"2026-03-31","holder_table":"reporting","shares":300000,"book_value_yen":512000000,"prior_shares":300000,"prior_book_value_yen":386000000,"purpose_ja":"取引先(原材料等の仕入先)として、事業上の関係を維持・強化することで、企業基盤の安定化を図り、中長期的に企業価値の向上を図るために株式を保有しています。定量的な保有効果については記載が困難であります。保有の合理性は、「保有の合理性を検証する方法」（注３）に記載したような観点に着目し、取締役会において、保有の適否を検証しています。","reciprocal":"有","pct_outstanding":1.1636778441673228,"pct_unavailable":null,"pct_basis_period_end":"2025-11-30","pct_share_classes":1,"pct_of_holder_equity":0.06018381925106409,"pct_of_holder_assets":0.046271401652937375,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":850727000000,"holder_total_assets_yen":1106515000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"ＯＡＴアグリオ株式会社","holder_name_en":"OAT Agrio Co., Ltd.","holder_sec_code":"4979","doc_id":"S100XSHI","period_end":"2025-12-31","holder_table":"reporting","shares":270000,"book_value_yen":444000000,"prior_shares":228000,"prior_book_value_yen":301000000,"purpose_ja":"農薬分野での技術交流先であり、中長期的な取引関係を維持するため","reciprocal":"有","pct_outstanding":1.0473100597505904,"pct_unavailable":null,"pct_basis_period_end":"2025-11-30","pct_share_classes":1,"pct_of_holder_equity":2.2248947684906795,"pct_of_holder_assets":1.1900932775812159,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":19956000000,"holder_total_assets_yen":37308000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"日産化学株式会社","holder_name_en":"Nissan Chemical Corporation","holder_sec_code":"4021","doc_id":"S100YIML","period_end":"2026-03-31","holder_table":"reporting","shares":242000,"book_value_yen":413000000,"prior_shares":242000,"prior_book_value_yen":310000000,"purpose_ja":"主に機能性材料・農業化学品セグメントにおける営業取引関係の維持・発展を保有目的としております。","reciprocal":"有","pct_outstanding":0.938700127628307,"pct_unavailable":null,"pct_basis_period_end":"2025-11-30","pct_share_classes":1,"pct_of_holder_equity":0.15942806628810544,"pct_of_holder_assets":0.11631247218920913,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":259051000000,"holder_total_assets_yen":355078000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社クレハ","holder_name_en":"KUREHA CORPORATION","holder_sec_code":"4023","doc_id":"S100YFHO","period_end":"2026-03-31","holder_table":"reporting","shares":234148,"book_value_yen":399000000,"prior_shares":234148,"prior_book_value_yen":300000000,"purpose_ja":"化学製品事業セグメントにおける農薬・医薬分野等の販売取引先であり、同社株式は、主として取引関係等の円滑化のために保有しています。","reciprocal":"有","pct_outstanding":0.908242799520301,"pct_unavailable":null,"pct_basis_period_end":"2025-11-30","pct_share_classes":1,"pct_of_holder_equity":0.24147718676051394,"pct_of_holder_assets":0.11789247260994433,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":165233000000,"holder_total_assets_yen":338444000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"日本新薬株式会社","holder_name_en":"Nippon Shinyaku Co., Ltd.","holder_sec_code":"4516","doc_id":"S100YGRG","period_end":"2026-03-31","holder_table":"reporting","shares":83490,"book_value_yen":142000000,"prior_shares":83490,"prior_book_value_yen":107000000,"purpose_ja":"協力関係の構築を目的に株式を保有しています。定量的な保有効果を示す事が困難なことから記載は省略していますが、「保有目的の合理性」と保有資産としての「経済的合理性」を検証し、2026年4月の取締役会において検証結果を確認、保有の可否を判断しています。","reciprocal":"有","pct_outstanding":0.3238515440317659,"pct_unavailable":null,"pct_basis_period_end":"2025-11-30","pct_share_classes":1,"pct_of_holder_equity":0.04870502930876588,"pct_of_holder_assets":0.04099792411919425,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":291551000000,"holder_total_assets_yen":346359000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"日本曹達株式会社","holder_name_en":"Nippon Soda Co., Ltd.","holder_sec_code":"4041","doc_id":"S100YJKO","period_end":"2026-03-31","holder_table":"reporting","shares":52440,"book_value_yen":89000000,"prior_shares":52440,"prior_book_value_yen":67000000,"purpose_ja":"（保有目的）製品の販売等の取引関係の強化（定量的な保有効果）（注）","reciprocal":"有","pct_outstanding":0.20341088716044803,"pct_unavailable":null,"pct_basis_period_end":"2025-11-30","pct_share_classes":1,"pct_of_holder_equity":0.04318417809349132,"pct_of_holder_assets":0.028961455231772994,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":206094000000,"holder_total_assets_yen":307305000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"長瀬産業株式会社","holder_name_en":"NAGASE & CO., LTD.","holder_sec_code":"8012","doc_id":"S100YK28","period_end":"2026-03-31","holder_table":"reporting","shares":16698,"book_value_yen":28000000,"prior_shares":null,"prior_book_value_yen":null,"purpose_ja":"生活関連セグメントを中心に、農産分野関連の取引を行っており、同社との良好な関係維持、取引の強化および事業の拡大を図るために保有しております。(注)2","reciprocal":"有","pct_outstanding":0.06477030880635319,"pct_unavailable":null,"pct_basis_period_end":"2025-11-30","pct_share_classes":1,"pct_of_holder_equity":0.006451241287944243,"pct_of_holder_assets":0.003212755557493408,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":434025000000,"holder_total_assets_yen":871526000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"日本化薬株式会社","holder_name_en":"NIPPON KAYAKU CO.,LTD.","holder_sec_code":"4272","doc_id":"S100YD4R","period_end":"2026-03-31","holder_table":"reporting","shares":16000,"book_value_yen":27000000,"prior_shares":16000,"prior_book_value_yen":20000000,"purpose_ja":"（保有目的）ライフサイエンス事業領域における販売・調達先として関係の維持、強化を図るため（定量的な保有効果）　（注）1","reciprocal":"有","pct_outstanding":0.06206281835559055,"pct_unavailable":null,"pct_basis_period_end":"2025-11-30","pct_share_classes":1,"pct_of_holder_equity":0.009639276840030846,"pct_of_holder_assets":0.006771397616468039,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":280104000000,"holder_total_assets_yen":398736000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"クニミネ工業株式会社","holder_name_en":"KUNIMINE INDUSTRIES CO.,LTD.","holder_sec_code":"5388","doc_id":"S100YOPN","period_end":"2026-03-31","holder_table":"reporting","shares":4339,"book_value_yen":7406000,"prior_shares":4339,"prior_book_value_yen":5575000,"purpose_ja":"(保有目的)安定的な営業取引を図る目的であります","reciprocal":"無","pct_outstanding":0.01683066055280671,"pct_unavailable":null,"pct_basis_period_end":"2025-11-30","pct_share_classes":1,"pct_of_holder_equity":0.03199984099457891,"pct_of_holder_assets":0.027588431707921728,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":23143865000,"holder_total_assets_yen":26844585000,"implausible":false,"reciprocal_held_both_ways":false}],"reclassified":[],"reclassified_note":"As filed, from the annual report's 保有目的を変更した投資株式 table. direction=to_pure means the filer moved the holding from a policy shareholding to 純投資目的 (pure investment); the shares are not necessarily sold, and the position leaves the named policy table in the year of the change. direction=to_policy is the reverse. fy_of_change_ja is the fiscal year the filer states the change took effect, verbatim — some filers list more than one. A filing repeats these rows for several years after the change, so this is a standing disclosure, not a one-year event.","implausible_note":"A row is flagged implausible when its two filed numbers are mutually impossible — book value ÷ shares of ¥1,000,000 or more, which no listed Japanese share reaches. It is a filer tagging error (a value entered at the wrong scale, or a share count in thousands), not an extraction error: the values match the filing's XBRL exactly. Flagged rows are still returned, exactly as filed, but are excluded from the yen aggregates here and counted in excluded_positions / excluded_yen so the exclusion is visible.","notes":[{"holder_table":"reporting","note_no":"1","text_ja":"（注）１　貸借対照表計上額が資本金額の100分の１を超えている17銘柄について記載しております。"},{"holder_table":"reporting","note_no":"2","text_ja":"２　定量的な保有効果は記載が困難であるため、記載しておりません。なお、保有の適否に関する検証は「保有方針及び保有の合理性を検証する方法並びに個別銘柄の保有の適否に関する取締役会等における検証の内容」に記載しております。"}],"notes_note":"The filing's own numbered footnotes to the named policy table, verbatim. The XBRL numbers them (注)1, (注)2 … and gives no link back to a row, so a note is tied to a position only where it names that issuer.","flows":[{"holder_table":"reporting","share_class":"listed","issues_increased":null,"acquisition_cost_yen":null,"issues_decreased":1,"sale_proceeds_yen":347000000,"entity_scope":"parent_only","share_scope":"listed"},{"holder_table":"reporting","share_class":"unlisted","issues_increased":1,"acquisition_cost_yen":55000000,"issues_decreased":null,"sale_proceeds_yen":null,"entity_scope":"parent_only","share_scope":"unlisted"}],"flows_note":"The filer's own tally, as filed, of how many issues increased or decreased during the year and the yen involved — acquisition cost for increases, sale proceeds for decreases. Read against the reclassification table this separates what was actually sold from what merely changed category. Counts are as filed and are not corrected for filer tagging errors.","no_reduction_measure":"This product holds sale proceeds (売却価額), as filed, for one fiscal year. It does NOT hold a book-value-reduction measure. The two are different measures and must never be presented as equivalent.","scale":{"policy_total_yen":18022000000,"listed_yen":17991000000,"unlisted_yen":31000000,"listed_issues":17,"unlisted_issues":10,"equity_yen":52900000000,"equity_basis":"jgaap_consolidated","total_assets_yen":77600000000,"assets_basis":"jgaap_consolidated","pct_of_equity":34.06805293005671,"pct_of_assets":23.22422680412371,"equity_basis_label":"Consolidated net assets (Japanese GAAP)","assets_basis_label":"Consolidated net assets (Japanese GAAP)","equity_calc":"total policy shareholdings ÷ shareholders' equity × 100, both as filed in this annual securities report","assets_calc":"total policy shareholdings ÷ total assets × 100, both as filed in this annual securities report"},"scale_entities":[{"holder_table":"reporting","share_class":"listed","book_value_yen":17991000000,"issue_count":17,"holder_table_label":"The filer itself","entity_scope":"parent_only","share_scope":"listed"},{"holder_table":"reporting","share_class":"unlisted","book_value_yen":31000000,"issue_count":10,"holder_table_label":"The filer itself","entity_scope":"parent_only","share_scope":"unlisted"}],"scale_history":[{"year":"2021","period_end":"2021-11-30","policy_total_yen":1029000000,"equity_yen":34220000000,"equity_basis":"jgaap_consolidated","pct_of_equity":3.007013442431327,"pct_of_assets":1.9793409890934273},{"year":"2022","period_end":"2022-11-30","policy_total_yen":9511000000,"equity_yen":38240000000,"equity_basis":"jgaap_consolidated","pct_of_equity":24.871861924686193,"pct_of_assets":16.521905291317793},{"year":"2023","period_end":"2023-11-30","policy_total_yen":16781000000,"equity_yen":46770000000,"equity_basis":"jgaap_consolidated","pct_of_equity":35.87983750267265,"pct_of_assets":24.868477600438656},{"year":"2024","period_end":"2024-11-30","policy_total_yen":11983000000,"equity_yen":46198000000,"equity_basis":"jgaap_consolidated","pct_of_equity":25.93835230962379,"pct_of_assets":18.344508741312268},{"year":"2025","period_end":"2025-11-30","policy_total_yen":18022000000,"equity_yen":52900000000,"equity_basis":"jgaap_consolidated","pct_of_equity":34.06805293005671,"pct_of_assets":23.22422680412371}],"scale_note":"The policy total is Official (as filed) — the filing's own total carrying amount for the whole policy bucket, listed and unlisted, summed across the entities the filing discloses. It is a floor: holdings at group companies the filing does not name are disclosed nowhere and are not included. The percentages are calculated, not filed, and carry their formula. equity_basis names which figure the denominator is, because filers report under Japanese, IFRS or US accounting standards and an adopter of the latter two stops tagging the Japanese consolidated figure — a parent-only denominator is a different measure and is labelled as one, never silently mixed with a group figure. Percentages are null where equity or total assets is missing or not positive; missing is never shown as zero.","scale_reference":"ISS's Japan proxy voting guidelines recommend a vote against the top executive at a company that allocates 20 percent or more of its net assets to cross-shareholdings, a policy effective from February 2022. ISS counts unilateral holdings, not only mutual ones.","ownership_calc":"shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end","ownership_note":"Derived, not filed. The denominator is the issuer's own reported issued shares less treasury shares, from its annual report nearest this holding's fiscal year end on either side — pct_basis_period_end gives that date, and it can fall after the holding's date where that report is the closer one. For a single-class listed stock this equals the stake's share of market capitalisation. It is null where the issuer files no annual report we hold; where the issuer's share count moves by half or more across the window, because a split or issue makes the share base indeterminate; and where the result would exceed 100%, which is a data fault rather than a stake. It is less exact where the issuer has more than one share class (pct_share_classes > 1), because treasury shares are reported across all classes.","holder_share_calc":"this position's book value ÷ the holder's shareholders' equity (or total assets) × 100, both as filed in the holder's own annual securities report","holder_share_note":"The mirror of pct_outstanding. That sizes a stake against the ISSUER — how much of the issuer this holder owns. pct_of_holder_equity and pct_of_holder_assets size the same position against the HOLDER: how much of its own capital is committed to this one name. Calculated, not filed. Null where the holder's filing gives no usable denominator, never zero. holder_equity_basis says which accounting figure the denominator is, and a parent_only basis is not comparable with a consolidated one. A position CAN legitimately exceed 100% of equity — a holder whose book equity is smaller than one long-held stake is a real and commercially interesting case, not an error — so no ceiling is imposed. Extreme values are worth checking against the filing: where the position's own two filed numbers are mutually impossible the row is marked `implausible`, but that test catches only scale errors visible per share, so it does not catch every bad figure. The book value and share count are returned alongside so the reader can check.","action_calc":"keyword match over the filing's own stated purpose and table footnotes: 株式分割、株式併合、株式交換、株式移転、会社分割、合併、持株会社、商号変更、公開買付、上場廃止","ratio_calc":"current shares ÷ prior shares where that ratio is an exact whole number (or its exact reciprocal) — the signature of a split or a consolidation rather than a trade","history":[{"year":"2021","period_end":"2021-11-30","named_holdings":17,"book_value_yen":9172000000},{"year":"2022","period_end":"2022-11-30","named_holdings":17,"book_value_yen":9491000000},{"year":"2023","period_end":"2023-11-30","named_holdings":17,"book_value_yen":16763000000},{"year":"2024","period_end":"2024-11-30","named_holdings":17,"book_value_yen":11951000000},{"year":"2025","period_end":"2025-11-30","named_holdings":17,"book_value_yen":17991000000}],"history_note":"One point per annual report filed. Each year's book value is as filed; book values are fair-valued at period end, so a change reflects both trading and market moves.","provenance":{"trust":"official","note":"Figures exactly as filed in each company's 有価証券報告書 (annual securities report), EDINET. Raw filings archived with SHA-256; doc_id links to the source filing."}}